BDX - Becton, Dickinson and Company

NYSE - NYSE Delayed Price. Currency in USD
248.11
-0.11 (-0.04%)
At close: 4:00PM EDT

248.11 0.00 (0.00%)
After hours: 4:43PM EDT

Stock chart is not supported by your current browser
Previous Close 248.22
Open 248.29
Bid 248.35 x 1000
Ask 248.35 x 900
Day's Range 244.12 - 248.80
52 Week Range 208.62 - 265.87
Volume 1,124,401
Avg. Volume 1,454,970
Market Cap 66.923B
Beta (3Y Monthly) 1.26
PE Ratio (TTM) 74.40
EPS (TTM) 3.34
Earnings Date Jul 31, 2019 - Aug 5, 2019
Forward Dividend & Yield 3.08 (1.24%)
Ex-Dividend Date 2019-06-06
1y Target Est 260.00
Trade prices are not sourced from all markets
  • Barrons.com 11 hours ago

    A Mutual-Fund Fixer Designs His Own Fund, With Flexibility in Mind

    David King spent the bulk of his entire career turning around mutual funds, but now he runs a fund of his own design, the Columbia Flexible Capital Income fund.

  • Moody's 2 days ago

    Becton, Dickinson and Company -- Moody's announces completion of a periodic review of ratings of Becton, Dickinson and Company

    Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Becton, Dickinson and Company and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.

  • BD Statement on FDA Circulatory System Devices Panel Regarding Paclitaxel-Coated Devices
    PR Newswire 6 days ago

    BD Statement on FDA Circulatory System Devices Panel Regarding Paclitaxel-Coated Devices

    Additionally, BD presented its own data confirming that the benefits outweigh the risks for LUTONIX® Drug-Coated Balloons (DCBs) in SFA. Over the past several months, BD has been working diligently to obtain all available patient follow up data and collaborating with FDA, professional clinical organizations and industry to investigate the important issue of DCB safety.

  • Top Research Reports for Adobe, Charter Communications & HCA Healthcare
    Zacks 6 days ago

    Top Research Reports for Adobe, Charter Communications & HCA Healthcare

    Top Research Reports for Adobe, Charter Communications & HCA Healthcare

  • Merit Medical Acquires Brightwater Medical for $35 Million
    Zacks 8 days ago

    Merit Medical Acquires Brightwater Medical for $35 Million

    The Brightwater Medical-acquisition broadens Merit Medical's (MMSI) product offerings.

  • Markit 8 days ago

    See what the IHS Markit Score report has to say about Becton Dickinson and Co.

    Becton Dickinson and Co NYSE:BDXView full report here! Summary * Perception of the company's creditworthiness is positive * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for BDX with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding BDX are favorable, with net inflows of $9.79 billion. Additionally, the rate of inflows is increasing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | PositiveThe current level displays a positive indicator. BDX credit default swap spreads are near the lowest level of the last three years and indicate the market's continued positive perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Here is What Hedge Funds Think About Becton, Dickinson and Company (BDX)
    Insider Monkey 12 days ago

    Here is What Hedge Funds Think About Becton, Dickinson and Company (BDX)

    "Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much. Cumulatively, through this week, it has been a 122% differential (up 52% for value vs up 174% for growth). This appears to be the longest and most severe drought for value […]

  • Is There Now An Opportunity In Becton, Dickinson and Company (NYSE:BDX)?
    Simply Wall St. 14 days ago

    Is There Now An Opportunity In Becton, Dickinson and Company (NYSE:BDX)?

    Becton, Dickinson and Company (NYSE:BDX) saw significant share price movement during recent months on the NYSE, rising...

  • Why Is Becton Dickinson (BDX) Up 3.7% Since Last Earnings Report?
    Zacks 18 days ago

    Why Is Becton Dickinson (BDX) Up 3.7% Since Last Earnings Report?

    Becton Dickinson (BDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Is Budimex SA's (WSE:BDX) ROE Of 35% Impressive?
    Simply Wall St. 18 days ago

    Is Budimex SA's (WSE:BDX) ROE Of 35% Impressive?

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

  • PR Newswire 22 days ago

    BD Announces Pricing and Upsizing of Tender Offers

    FRANKLIN LAKES, N.J. , June 4, 2019 /PRNewswire/ -- Becton, Dickinson and Company (NYSE: BDX) (the " Company " or " BD ") today announced the consideration payable in connection with ...

  • PR Newswire 22 days ago

    New Report Sheds Light on Health Care's 'Hidden' Epidemic - Hospital Drug Diversion - and its Role in the Opioid Crisis

    FRANKLIN LAKES, N.J., June 4, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (BDX), a leading global medical technology company, today released a new report based on an independent national survey that examines drug diversion in U.S. hospitals, an underreported contributor to the opioid epidemic. Hospital drug diversion, when a health care worker "diverts" opiates or other controlled substances away from patients for personal use or sale, remains a significant challenge that is largely underdiscussed. Denial of the problem in their own hospitals – Executives and providers (nurses, pharmacists and anesthesiologists) may be in denial about the diversion problem in their own facilities.

  • PR Newswire 22 days ago

    BD Announces Early Tender Results

    FRANKLIN LAKES, N.J. , June 3, 2019 /PRNewswire/ -- Becton, Dickinson and Company (NYSE: BDX) (the " Company " or " BD ") today announced the early tender results for its previously ...

  • PR Newswire 26 days ago

    BD to Present at the Goldman Sachs 40th Annual Global Healthcare Conference

    FRANKLIN LAKES, N.J. , May 31, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Goldman Sachs ...

  • Would Becton, Dickinson and Company (NYSE:BDX) Be Valuable To Income Investors?
    Simply Wall St. last month

    Would Becton, Dickinson and Company (NYSE:BDX) Be Valuable To Income Investors?

    Dividend paying stocks like Becton, Dickinson and Company (NYSE:BDX) tend to be popular with investors, and for good...

  • Moody's last month

    Becton Dickinson Euro Finance S.a.r.l. -- Moody's assigns Ba1 rating to Becton Dickinson's proposed euro note offering

    Moody's Investors Service ("Moody's") today assigned Ba1 ratings to the senior unsecured notes to be offered by Becton Dickinson Euro Finance S.a.r.l. As part of the refinancing, BD plans to repay at maturity its euro 1 billion notes due in June 2019 and to tender for certain other outstanding notes of BD.

  • PR Newswire last month

    Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities

    FRANKLIN LAKES, N.J., May 20, 2019 /PRNewswire/ -- Becton, Dickinson and Company (BDX) (the "Company" or "BD") today announced that it has commenced tender offers to purchase for cash the debt securities issued by the Company listed in the table below (collectively, the "Securities" and each a "series"). The Company reserves the right, but is under no obligation, to increase any of the Tender SubCaps in the table above or the aggregate tender cap at any time, subject to applicable law.

  • Becton, Dickinson Muscles Through a Tough Quarter
    Motley Fool last month

    Becton, Dickinson Muscles Through a Tough Quarter

    Things should pick up in the back half of the fiscal year.

  • Moody's last month

    Becton, Dickinson and Company -- Moody's affirms Becton Dickinson's ratings (CFR at Ba1), outlook revised to positive

    Moody's Investors Service ("Moody's") today affirmed all of Becton, Dickinson & Company's ("BD") ratings including the Ba1 Corporate Family Rating, Ba1-PD Probability of Default Rating, Not Prime commercial paper rating, SGL-1 Speculative Grade Liquidity rating and the Ba1 senior unsecured rating. "The revision in the outlook to positive considers the deleveraging progress that BD has made since the closing of the Bard acquisition in December 2017" said Moody's Senior Vice President Scott Tuhy.

  • TheStreet.com last month

    The Charts of Becton, Dickinson Need More 'Work' Before a Rally

    In this daily bar chart of BDX, below, we can see that prices made a peak in early October and prices weakened into late December/early January. The daily On-Balance-Volume (OBV) line has declined since early April and suggests that sellers of BDX have been more aggressive. In this weekly bar chart of BDX, below, we can see a potential topping or bearish pattern from late 2017 with a possible "neckline" across the $210 level.

  • Benzinga last month

    Jim Cramer Gives His Opinion On Becton Dickinson, Fox, Puma Biotech And More

    On CNBC's "Mad Money Lightning Round,"  Jim Cramer said he would hold off for now from Village Farms International Inc (NASDAQ: VFF ). He is not a buyer of Sailpoint Technologies Holdings Inc ...

  • Benzinga last month

    Barclays Upgrades Becton Dickinson, Says Market Overreacted To FDA's Drug-Coated Balloon Update

    Becton Dickinson and Co’s (NYSE: BDX ) stock has lost more than 10 percent since March 15 in response to the FDA update on drug-coated balloons, or DCBs.  The market seems to have overreacted to the news, ...

  • Is Budimex SA's (WSE:BDX) Balance Sheet Strong Enough To Weather A Storm?
    Simply Wall St. last month

    Is Budimex SA's (WSE:BDX) Balance Sheet Strong Enough To Weather A Storm?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...